Newsletter
Pharmacy Payment Challenges in 2024
Featured Partner | SoftWriter's Mark Fulton on decoding the decline in reimbursements amid the complex web of challenges in 2024.
Newsletter
Featured Partner | SoftWriter's Mark Fulton on decoding the decline in reimbursements amid the complex web of challenges in 2024.
Featured Partner | SoftWriters shares helpful tips to help your pharmacy get the most out of your SATO and Zebra printers in your long-term care pharmacy.
Newsletter
Announces the recipients of its first annual Excellence Awards
Podcast | PTMR News March 6, 2024 | RedSail Technologies Launches RxCash+, Elsevier Health Launches ClinicalKey AI, Cost Plus Drug Teams Up, Clarest Acquires Remedi, Divided Opinion Drug Importation
Newsletter
Featured Podcast | Framework Focus takes a look to the future with a lively panel discussion featuring three soon-to-be pharmacists from University of Pittsburgh's School of Pharmacy.
January/February 2024
Newsletter
PTMR publisher, Bill Lockwood, talks to Kevin Borcher, Pharm.D., about the latest ASAP (American Society for Automation in Pharmacy) standard, V5.0. Borcher played a key role in framing up Version 5.0. During the development of the new implementation guide, he served as VP for PDMP (prescription drug
Newsletter
Technology vendors, business partners, and industry experts gathered at the Don CeSar, St. Pete Beach, Fla., for the American Society for Automation in Pharmacy 2024 Annual Conference.
There is still much to be done to get to the DSCSA’s vision of an electronic, interoperable system to trace pharmaceutical products | Catalyst Corner | By Marsha Millonig
Newsletter
One opportunity for an additional revenue stream is for pharmacists to provide and bill for a multitude of clinical services | Viewpoints | By Patricia Milazzo and Logan Graham
Newsletter
Understanding what your pharmacy's patients are using to track their health and wellness can offer an opportunity to help them achieve their health goals in 2024 | Technology Corner | By Brent Fox
Newsletter
DIR fees, reimbursements, time constraints, regulatory requirements, and profitability are top of mind today, and this list seems to grow with every pharmacist you speak with. | Sponsored